Some studies revealed that treating colon cancer cell lines with various concentrations of the GSK-3β inhibitors reduced the viability of cells and stimulated apoptotic machinery in a dose-dependent way [43,44,45]. This evidence concerns the gene GSK3B and malignant colon neoplasm.